Our platform interrogates small RNA to identify molecular drivers of disease
AI-DRIVEN DISCOVERY DEFINES MOLECULAR PROFILES OF DISEASE CALLED SRNA-SIGNATURES
Small RNA are master regulators of gene expression found in blood and tissue
SRNA-SIGNATURES CHARACTERIZE TARGETABLE PATHWAYS THAT ARE SHARED BETWEEN GROUPS OF PATIENTS WITHIN A DISEASE INDICATION
Platform analyzes millions of sRNA features to create a signature that:
Classifies disease
Stratifies subjects
Predicts disease drivers
Designs RNA therapeutics
TARGETING THE SRNA-SIGNATURE CREATES A NEW CLASS OF RNA THERAPEUTICS
sRNA therapeutics are delivered using lipid nanoparticles and conjugates
High fidelity therapeutics derived from the sRNA-signatures enable unmatched precision
Advancements in lipid nanoparticle and conjugate chemistry enable drug delivery to multiple tissues
MACHINE LEARNING MINES AN EXPANDING MULTI-OMICS DATABASE TO ESTABLISH A MAP OF COMMON PATHWAY TARGETS ACROSS INDICATIONS
